Medecins Sans Frontieres (MSF) has called on Johnson & Johnson to cut the price of "gamechanging" tuberculosis (TB) drug bedaquline by half, so that a 20-month supply would cost $600. Sharonann Lynch, a policy adviser at MSF, criticised the US system in which non-profit and philanthropic contributors to a drug's development had no say in its final price. " In 2014, when bedaquiline was commercially launched, a six-month supply cost $900. The World Health Organisation (WHO) estimates that TB kills more than 2 million people every year, mostly children under five.
Medecins Sans Frontieres (MSF) has called on Johnson & Johnson to cut the price of "gamechanging" tuberculosis (TB) drug bedaquline by half, so that a 20-month supply would cost $600. Sharonann Lynch, a policy adviser at MSF, criticised the US system in which non-profit and philanthropic contributors to a drug's development had no say in its final price. In 2014, when bedaquiline was commercially launched, a six-month supply cost $900. The World Health Organisation (WHO) estimates that TB kills more than 2 million people every year, mostly children under five.